Skip to main content

Test Price

900 AED

✅ Home Collection Available

Enhanced Liver Fibrosis (ELF) Panel in UAE | 900 AED | DHA-Regulated

Executive Summary & Core Metrics

Clinical Certainty, UAE-Compliant Logistics, and Direct Expert Guidance – All in One Test. Our Enhanced Liver Fibrosis Panel delivers 99.9% diagnostic sensitivity via ISO 9001:2015‑accredited processing, paid hospital‑grade home collection with specialist‑verified cold‑chain transport, and telephonic post‑test clinical interpretation. Direct insurance billing verification is available through WhatsApp.

ISO 9001:2015 Certified (INT/EGQ/2509DA/3139) DHA-Regulated Home Collection VIP Mobile Phlebotomy (8 AM‑11 PM) WhatsApp Support: +971 54 548 8731

Test Overview & Methodology

The Enhanced Liver Fibrosis (ELF) Panel is a non‑invasive serum biomarker assay that quantifies three direct fibrosis markers – hyaluronic acid, PIIINP, and TIMP‑1 – to stratify liver fibrosis severity with high accuracy, reducing the need for liver biopsy. For UAE patients and clinicians, it provides a reproducible, guideline‑endorsed tool for monitoring chronic liver disorders under DHA‑aligned protocols.

Our ELF Panel vs. Common Alternatives

Feature Our ELF Panel (DNA Labs UAE) Closest Alternative (e.g., FibroTest/Echosens)
Precision Chemiluminescent Microparticle Immunoassay (CMIA) – direct quantitative fibrosis markers Indirect algorithm combining α2‑macroglobulin, haptoglobin, GGT, bilirubin, etc.
Methodology Fully automated, ISO‑accredited, standardized on Siemens ADVIA Centaur platform Proprietary algorithm; limited UAE‑based quality‑control transparency
Turnaround Time Sample collected Mon/Thu by 4 pm → next‑day report Often 2–4 days due to send‑out logistics

Pre-Test Preparation & Logistics

  • Overnight fasting (10‑12 hours) mandatory – water is permitted.
  • Do not discontinue prescribed medications without physician consultation.
  • Sample: 3 mL serum (min. 1.5 mL) from 1 SST tube; ship refrigerated or frozen.
  • Collection schedule: Mon / Thu by 4 pm; report available next day.
  • Home collection available daily 8 AM‑11 PM with cold‑chain transport and VIP mobile phlebotomy.

Physician Insight & Safety Protocols

“The ELF panel provides a robust non‑invasive snapshot of hepatic fibrogenesis. However, its interpretation must be integrated with clinical history, imaging, and other laboratory data. No single biomarker supersedes the full clinical picture. I always emphasize that results should guide, not replace, a hepatologist’s clinical judgment.”

— Dr. Ajay Singh, General Practitioner, DHA Reg. No. 36234132

Advisory: Do Not Discontinue Medications

Do not discontinue any prescribed medication without consulting your doctor, even if ELF results are within the reference interval. Some medications can influence fibrosis marker levels, but abrupt discontinuation may worsen underlying conditions.

Safety Exclusion Criteria & Emergency Red Flags

  • Exclusion: Unstable acute hepatitis, active cholangitis, or any condition requiring urgent inpatient care. This panel is not a substitute for acute liver diagnostics.
  • Exclusion: Known hypersensitivity to any component of the collection kit (though standard phlebotomy materials).
  • Red Flag: If you experience sudden severe right upper quadrant pain, jaundice, confusion, or haematemesis, seek immediate emergency care – do not delay for test results.
  • Red Flag: A prolonged prothrombin time or acute decompensation requires emergency evaluation regardless of ELF score.

Patient FAQ & Clinical Guidance

1. What does the Enhanced Liver Fibrosis (ELF) Panel measure and why is it preferred over biopsy?

The ELF panel directly measures three serum biomarkers – hyaluronic acid, procollagen III amino‑terminal peptide, and tissue inhibitor of metalloproteinase 1 – to provide an algorithmic fibrosis score that parallels liver biopsy staging without invasive sampling. This non‑invasive approach enables repeat testing for disease monitoring, early detection of fibrosis progression, and guided treatment decisions in fatty liver, viral hepatitis, and other chronic liver conditions.

2. How should I prepare for the ELF Panel blood draw, and why is overnight fasting mandatory?

Strict overnight fasting (10–12 hours) is mandatory to avoid lipaemia‑related analytical interference and to ensure accurate quantification of fibrosis markers, particularly hyaluronic acid, whose levels can be influenced by post‑prandial metabolic changes. You must also inform the phlebotomist of all current medications and supplements, as some may modulate TIMP‑1 or inflammatory cytokines; however, do not discontinue prescribed drugs without physician direction.

3. What do my ELF score results mean, and when should I see a hepatologist immediately?

An ELF score of <7.7 typically indicates none‑to‑mild fibrosis, 7.7–9.8 suggests moderate fibrosis, and ≥9.8 often correlates with advanced fibrosis or cirrhosis; however, these cut‑offs must be interpreted alongside liver biochemistry, imaging, and clinical context. You should seek an urgent hepatology consultation if your ELF score is ≥9.8, or if you develop new‑onset ascites, jaundice, or confusion, as these may signal decompensation requiring immediate intervention.

UAE Regulatory & Data Privacy Adherence

This laboratory service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient results are transmitted via encrypted DHA-approved digital channels. Home collection for minors requires documented guardian consent per Federal Decree-Law No. 4 of 2016 on Medical Liability.

Clinical & Logistical Metadata

Test Name Enhanced Liver Fibrosis (ELF) Panel
Price (AED) 900 AED
Turnaround Time Next day (if collected Mon/Thu by 4pm)
Sample Type / Matrix Serum (SST tube, 3 mL)
Methodology Used Chemiluminescent Microparticle Immunoassay (CMIA) on Siemens ADVIA Centaur
ICD-10-CM Code K74.0, Z13.89, K74.69
LOINC Code 94862-9
DHA Facility License & Laboratory Address DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians